The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …

Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-
19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA virus of the family
Coronaviridae, causes coronavirus disease 2019 (COVID-19), an influenza-like disease that …

Oral booster-single strain probiotic bifidobacteria could be a potential strategy for SARS-
CoV-2. This study aims to evaluate the role of oral probiotic Bifidobacterium on …

Therapeutic approaches with immune‐modulatory effects such as probiotics and prebiotics
adjuvant therapy may be essential to combat against COVID‐19 pandemic. The present trial …

Background: To examine the incidence of diarrhea in severe and critical coronavirus
disease 2019 (COVID-19) patients, and to observe the efficacy and prognosis of probiotic …

The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which rages all over the world and …

Background: COVID-19 disease, which typically presents with respiratory symptoms, can
trigger intestinal inflammation through SARS-CoV-2 replication in the gastrointestinal tract …

Abstract Background Coronavirus disease-19 (COVID-19) is an infectious disease
transmitted by the virus responsible for the severe acute respiratory syndrome 2 (SARS-CoV …

Background and aims Oral probiotic supplementation may be a beneficial adjunctive
therapy for patients with symptomatic COVID-19. However, its safety and efficacy are …